Renal Toxicity of Rosuvastatin: A Case Report

This is a report of a 64-year-old man who developed acute kidney injury (AKI) associated with high-dose rosuvastatin. He had been treated with statins for several years due to coronary artery disease, hypertension, and hyperlipidemia. He had initially been treated with simvastatin, though it was changed to rosuvastatin for stronger effects on cholesterol and cardiovascular risk reduction. About 12 months after getting rosuvastatin 40 mg per day, AKI was detected. Though other factors were likely contributing, the AKI appeared to be nephrotoxic in nature. There were two medications on his list, rosuvastatin and pantoprazole, which plausibly could cause reduced kidney function, and we discussed a trial of medication withdrawal. He had severe esophageal disease, which was at risk of a flare with coming off the pantoprazole, so we elected to stop rosuvastatin first. After stopping rosuvastatin, the kidney function returned to baseline, and the abnormal urine testing resolved.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-11-03
DOI
https://doi.org/10.7759/cureus.96013
Citations
1
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Renal Toxicity of Rosuvastatin: A Case Report

Michael Shye, Carl Schulze
1 citations
Cureus
Lipoproteins and Cardiovascular Health
2.01
article

Renal Toxicity of Rosuvastatin: A Case Report

Michael Shye, Carl Schulze
article en
1 citations

Abstract

This is a report of a 64-year-old man who developed acute kidney injury (AKI) associated with high-dose rosuvastatin. He had been treated with statins for several years due to coronary artery disease, hypertension, and hyperlipidemia. He had initially been treated with simvastatin, though it was changed to rosuvastatin for stronger effects on cholesterol and cardiovascular risk reduction. About 12 months after getting rosuvastatin 40 mg per day, AKI was detected. Though other factors were likely contributing, the AKI appeared to be nephrotoxic in nature. There were two medications on his list, rosuvastatin and pantoprazole, which plausibly could cause reduced kidney function, and we discussed a trial of medication withdrawal. He had severe esophageal disease, which was at risk of a flare with coming off the pantoprazole, so we elected to stop rosuvastatin first. After stopping rosuvastatin, the kidney function returned to baseline, and the abnormal urine testing resolved.

CureusVol. 17(11)
University of California, Los Angeles (US)
Openalex Percentile: Top 11%
Lipoproteins and Cardiovascular Health
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.